论文部分内容阅读
工信部、国家发改委、科学技术部、商务部、国家卫生和计划生育委员会、国家食品药品监督管理总局等部门日前联合发布《医药工业发展规划指南》。《指南》提出,到2020年,规模效益稳定增长,创新能力显著增强,产品质量全面提高,供应保障体系更加完善,国际化步伐明显加快,医药工业整体素质大幅提升。行业规模方面,《指南》提出,主营业务收入保持中高速增长,年均增速高于10%,占工业经济的比重显著提高。
Ministry of Industry and Information Technology, National Development and Reform Commission, Ministry of Science and Technology, Ministry of Commerce, National Health and Family Planning Commission, State Food and Drug Administration and other departments jointly released the “Guidelines for the Development of Pharmaceutical Industry.” According to the Guide, by 2020, the scale efficiency will be steadily increased, the innovation capability will be significantly enhanced, the quality of products will be improved in an all-round way, the supply guarantee system will be further improved, the pace of internationalization will be significantly accelerated, and the overall quality of the pharmaceutical industry will be greatly enhanced. As for the scale of the industry, the Guideline states that the income from main business will maintain a medium and high-speed growth with an average annual growth rate of over 10% and a significant increase in the proportion of industrial economy.